That does not make them illegitimatecompounding under section 503A of the Federal Food, Drug, and Cosmetic Act is a well-established practice for patient-specific needsbut it does place an outsized responsibility on the prescriber and the pharmacy
Weight loss injectables can increase the risk of gallbladder disease, including gallstones and cholecystitis (inflammation of the gallbladder)
Making Bariatric Evaluation Referrals Even with advancements in AOMs, metabolic bariatric surgery remains a well-established and evidence-based obesity treatment option often recommended in conjunction with AOMs
Russell-Jones D, Vaag A, Schmitz O, Sethi BK, Lalic N, Antic S, Zdravkovic M, Ravn GM, Sim R